Genscript Biotech (01548): Unusual share price movement; unaware of the reason for the movement

Genscript Biotech (01548) announces that the Board of Directors of the Company has noted recent unusual fluctuations in the price of the Company's shares. The Board hereby provides the following information to shareholders and potential investors of the Company. Regarding the change in the board lot size of the Company from 2,000 shares to 1,000 shares (previous announcement). The Company notes that a certain financial media outlet has excerpted information from the previous announcement and disseminated a message alleging that the Company will close its trading counter, which may cause misunderstanding among investors. The Company kindly reminds its shareholders and potential investors that the temporary counter for trading shares in board lots of 2,000 shares will close at 4:10 p.m. on Wednesday, November 4, 2026. Recently, the Company successfully held its 2026 Annual Investor Open Day on October 30, 2026. The Group's business and operations remain normal, and there have been no material changes in business management and financial condition. After making such enquiries as are reasonable in the circumstances, the Board confirms that, as at the date of this announcement, save as disclosed in this announcement, the Board is not aware of any reason for the fluctuations in the share price, nor is it aware of any inside information that is required to be disclosed under Part XIVA of the Securities and Futures Ordinance.